Clinical Trial Update: Induction of Immunogenicity With Different Doses of Grass MATA in Subjects Allergic to Grass and Rye Pollen [Phase 2]

View source ↗

Summary

Phase 2 trial investigating immunogenicity of Grass MATA at different doses in subjects with grass and rye pollen allergy; study is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Allergic Rhinitis

Drugs mentioned

• Grass MATA

Snippet

Sponsor: Allergy Therapeutics | Conditions: Type I Hypersensitivity | Phase 2 | Status: COMPLETED